| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1022974974 |
| P356 | DOI | 10.1186/1471-2407-8-266 |
| P932 | PMC publication ID | 2564978 |
| P698 | PubMed publication ID | 18803879 |
| P5875 | ResearchGate publication ID | 23268993 |
| P50 | author | Xinbao Hao | Q55122011 |
| P2093 | author name string | Min Zhang | |
| Daiming Fan | |||
| Liang Xu | |||
| Yang Meng | |||
| Qing Ji | |||
| Jeffrey Desano | |||
| P2860 | cites work | Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells | Q21195157 |
| The Bcl-2 apoptotic switch in cancer development and therapy | Q24620437 | ||
| ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome | Q24657877 | ||
| Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells | Q28246460 | ||
| Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells | Q28249223 | ||
| Identification and expansion of the tumorigenic lung cancer stem cell population | Q28259332 | ||
| let-7 regulates self renewal and tumorigenicity of breast cancer cells | Q28261263 | ||
| Identification of pancreatic cancer stem cells | Q28286997 | ||
| MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells | Q28287986 | ||
| A microRNA component of the p53 tumour suppressor network | Q28305330 | ||
| Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv | Q28364442 | ||
| Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis | Q29547575 | ||
| An inhibitor of Bcl-2 family proteins induces regression of solid tumours | Q29547595 | ||
| Transcriptional activation of miR-34a contributes to p53-mediated apoptosis | Q29619556 | ||
| Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma | Q29620604 | ||
| The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation | Q29620694 | ||
| Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness | Q33250633 | ||
| Overcoming bcl-2- and p53-mediated resistance in prostate cancer | Q33586871 | ||
| BCL-2 in prostate cancer: a minireview | Q34168174 | ||
| Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy | Q34328569 | ||
| BCL-2 family: regulators of cell death | Q34468840 | ||
| Stem cells in normal breast development and breast cancer | Q35548236 | ||
| An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells | Q36288990 | ||
| The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential | Q36375771 | ||
| BCL2 family in DNA damage and cell cycle control | Q36501194 | ||
| Cancer stem cells and oncology therapeutics | Q36667691 | ||
| Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer | Q36849195 | ||
| OncomiRs: the discovery and progress of microRNAs in cancers | Q36951319 | ||
| microRNA and stem cell function | Q36995222 | ||
| The guardian's little helper: microRNAs in the p53 tumor suppressor network | Q37023130 | ||
| MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth | Q38298486 | ||
| Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa | Q39958561 | ||
| MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas | Q40073679 | ||
| p53-mediated activation of miRNA34 candidate tumor-suppressor genes. | Q40102003 | ||
| Isolation and characterization of human gastric cell lines with stem cell phenotypes | Q40103732 | ||
| Double identity for proteins of the Bcl-2 family | Q41508318 | ||
| Bcl-2 family proteins: strategies for overcoming chemoresistance in cancer | Q41515360 | ||
| Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. | Q41668626 | ||
| Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. | Q44254389 | ||
| Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery | Q45733650 | ||
| Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest | Q48078984 | ||
| Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. | Q52188936 | ||
| Bcl-2 family proteins and mitochondria. | Q53947366 | ||
| Cancer stem cells in radiation resistance. | Q55467719 | ||
| Apoptosis and cancer chemotherapy | Q58282847 | ||
| Bcl-2 accelerates multistep prostate carcinogenesis in vivo | Q73187748 | ||
| BCL-2 gene family and the regulation of programmed cell death | Q77303933 | ||
| Expression of bcl-2 and the progression of human and rodent prostatic cancers | Q77556616 | ||
| Cancer stem cells and metastasis: lethal seeds | Q79188271 | ||
| Phospho Akt mediates multidrug resistance of gastric cancer cells through regulation of P-gp, Bcl-2 and Bax | Q80856775 | ||
| Breast cancer stem cells: the other side of the story | Q81303745 | ||
| Breast stem cells and cancer | Q81447020 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 266 | |
| P577 | publication date | 2008-09-21 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres | |
| P478 | volume | 8 |
| Q33515420 | A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB. |
| Q41758245 | A functional variant at miR-34a binding site in toll-like receptor 4 gene alters susceptibility to hepatocellular carcinoma in a Chinese Han population |
| Q36016499 | A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion |
| Q34210459 | A p53-dependent promoter associated with polymorphic tandem repeats controls the expression of a viral transcript encoding clustered microRNAs |
| Q38434033 | A subset of microRNAs defining the side population of a human malignant mesothelioma cell line |
| Q33577624 | A unified model of the hierarchical and stochastic theories of gastric cancer |
| Q54217180 | Antiproliferative effect of urolithin A, the ellagic acid-derived colonic metabolite, on hepatocellular carcinoma HepG2.2.15 cells by targeting Lin28a/let-7a axis. |
| Q35088734 | Apoptotic cell signaling in cancer progression and therapy |
| Q35345374 | Association between miR34b/c polymorphism rs4938723 and cancer risk: a meta-analysis of 11 studies including 6169 cases and 6337 controls |
| Q39735837 | C-T variant in a miRNA target site of BCL2 is associated with increased risk of human papilloma virus related cervical cancer--an in silico approach |
| Q27022017 | Can nanomedicines kill cancer stem cells? |
| Q38166579 | Cancer stem cells in pancreatic cancer |
| Q38713728 | Cancer stem cells in prostate cancer |
| Q38062840 | Cancer stem cells: the 'heartbeat' of gastric cancer |
| Q40339127 | Carbonic Anhydrase 9 mRNA/microRNA34a Interplay in Hypoxic Human Mammospheres |
| Q34391443 | Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases |
| Q26829583 | Clinical application of microRNA in gastric cancer in Eastern Asian area |
| Q26777882 | Common stemness regulators of embryonic and cancer stem cells |
| Q26771422 | Comparison of Prognostic MicroRNA Biomarkers in Blood and Tissues for Gastric Cancer |
| Q33801752 | Cross-talk between miRNA and Notch signaling pathways in tumor development and progression |
| Q46102699 | Crosstalk between miR-34a and Notch Signaling Promotes Differentiation in Apical Papilla Stem Cells (SCAPs). |
| Q47101032 | Crosstalk between the Notch signaling pathway and non-coding RNAs in gastrointestinal cancers |
| Q38020153 | DNA methylation of microRNA genes in multiple myeloma |
| Q37962577 | DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family |
| Q37229033 | DNA-damage-induced nuclear export of precursor microRNAs is regulated by the ATM-AKT pathway |
| Q36406800 | Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer |
| Q33688416 | Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another "double hit" lymphoma with very poor outcome? |
| Q21198847 | Down-regulated miR-9 and miR-433 in human gastric carcinoma |
| Q34992155 | Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance |
| Q39105165 | Downregulation of tumor suppressor MBP-1 by microRNA-363 in gastric carcinogenesis. |
| Q39204898 | Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway |
| Q37967610 | Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review |
| Q26752006 | Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer |
| Q38058972 | Epigenetic alterations involved in cancer stem cell reprogramming |
| Q37785993 | Epigenetic regulation of cell life and death decisions and deregulation in cancer |
| Q39465400 | Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer |
| Q28083951 | Epigenome-based personalized medicine in human cancer |
| Q55406904 | Establishment and characterization of a GES-1 human gastric epithelial cell line stably expressing miR-23a. |
| Q51750442 | Expressed microRNA associated with high rate of egg production in chicken ovarian follicles. |
| Q48110181 | Expression level of human miR-34a correlates with glioma grade and prognosis |
| Q90264208 | Expression levels of miR-34-family microRNAs are associated with TP53 mutation status in head and neck squamous cell carcinoma |
| Q54205015 | Expression of miR-34a in T-Cells Infected by Human T-Lymphotropic Virus 1. |
| Q64088413 | Friend or Foe: A Cancer Suppressor MicroRNA-34 Potentially Plays an Adverse Role in Vascular Diseases by Regulating Cell Apoptosis and Extracellular Matrix Degradation |
| Q42161265 | Genome-wide dissection of microRNA functions and cotargeting networks using gene set signatures |
| Q57477423 | Genomic Characterization of TP53-Wild-Type Esophageal Carcinoma |
| Q92921699 | High Mobility Group A (HMGA): Chromatin Nodes Controlled by a Knotty miRNA Network |
| Q36320924 | High-throughput sequencing of pituitary and hypothalamic microRNA transcriptome associated with high rate of egg production |
| Q33903223 | Implication of microRNAs in drug resistance for designing novel cancer therapy |
| Q28539851 | In-depth analysis shows synergy between erlotinib and miR-34a |
| Q46980193 | Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer |
| Q37109858 | Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia |
| Q64112826 | Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Proliferation and Metastasis of Osteosarcoma Cells by Targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b |
| Q38020729 | Macro-role of microRNA in gastric cancer |
| Q31148368 | MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells |
| Q38733014 | MiR-34a modulates ErbB2 in breast cancer |
| Q37692351 | MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene |
| Q37317570 | MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene |
| Q34036679 | MiRNA as potential biomarkers and therapeutic targets for gastric cancer. |
| Q37516328 | MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer |
| Q36690777 | MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer |
| Q37982054 | MiRNAs and LincRNAs: Could they be considered as biomarkers in colorectal cancer? |
| Q44139838 | MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma |
| Q55065193 | Micro-Economics of Apoptosis in Cancer: ncRNAs Modulation of BCL-2 Family Members. |
| Q35643732 | MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells |
| Q38178272 | MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas |
| Q37751868 | MicroRNA and drug resistance |
| Q38233783 | MicroRNA and signaling pathways in gastric cancer |
| Q37783909 | MicroRNA dysregulation in gastric cancer: a new player enters the game |
| Q37783459 | MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer |
| Q33497932 | MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells |
| Q42252202 | MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded samples |
| Q35224122 | MicroRNA regulation of cancer stem cells |
| Q37618041 | MicroRNA regulation of cancer stem cells and therapeutic implications |
| Q37924177 | MicroRNA replacement therapy for cancer |
| Q45342644 | MicroRNA-10a-5p and microRNA-34c-5p in laryngeal epithelial premalignant lesions: differential expression and clinicopathological correlation |
| Q36819807 | MicroRNA-125a represses cell growth by targeting HuR in breast cancer |
| Q40499327 | MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8. |
| Q39669051 | MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor |
| Q39281229 | MicroRNA-34 dysregulation in gastric cancer and gastric cancer stem cell |
| Q58548157 | MicroRNA-34 family in breast cancer: from research to therapeutic potential |
| Q39333849 | MicroRNA-34a inhibits human brain glioma cell growth by down-regulation of Notch1. |
| Q38929247 | MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2. |
| Q38828085 | MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2 |
| Q52629304 | MicroRNA-34a regulates proliferation and apoptosis of gastric cancer cells by targeting silent information regulator 1. |
| Q39351996 | MicroRNA-34a suppresses cell proliferation and induces apoptosis in U87 glioma stem cells |
| Q39124552 | MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment |
| Q47159125 | MicroRNA-449a maintains self-renewal in liver cancer stem-like cells by targeting Tcf3. |
| Q35165126 | MicroRNA-mediated drug resistance in breast cancer |
| Q38815056 | MicroRNA: a connecting road between apoptosis and cholesterol metabolism |
| Q35949461 | MicroRNAs and Gastroenterological Cancers |
| Q38184857 | MicroRNAs and anticancer drugs. |
| Q36116268 | MicroRNAs and cancer therapeutics |
| Q27022048 | MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer |
| Q57166469 | MicroRNAs and their role in environmental chemical carcinogenesis |
| Q37827156 | MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors |
| Q37381107 | MicroRNAs as therapeutic targets in chemoresistance |
| Q58923813 | MicroRNAs in Cancer Drug Resistance and Drug Sensitivity |
| Q38057979 | MicroRNAs in cancer diagnosis and therapy: from bench to bedside |
| Q38223219 | MicroRNAs in cancer stem cells: current status and future directions |
| Q38151490 | MicroRNAs in gastric cancer: from benchtop to bedside |
| Q38202662 | MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance |
| Q39101272 | MicroRNAs in melanoma development and resistance to target therapy |
| Q35033659 | MicroRNAs in skin and wound healing. |
| Q38496364 | MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer |
| Q34348967 | MicroRNAs, cancer and cancer stem cells |
| Q34154782 | MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers |
| Q26822633 | MicroRNAs: molecular features and role in cancer |
| Q58792269 | MicroRNA‑34b promotes proliferation, migration and invasion of Ewing's sarcoma cells by downregulating Notch1 |
| Q39605990 | Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. |
| Q47673159 | Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer |
| Q90725244 | NFIX Circular RNA Promotes Glioma Progression by Regulating miR-34a-5p via Notch Signaling Pathway |
| Q28074478 | NOTCH receptors in gastric and other gastrointestinal cancers: oncogenes or tumor suppressors? |
| Q38324456 | Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach |
| Q28079367 | Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system |
| Q34003691 | New promising drug targets in cancer- and metastasis-initiating cells |
| Q39868687 | No small matter: microRNAs - key regulators of cancer stem cells |
| Q38885498 | Noncoding RNAs Regulating Cancer Signaling Network |
| Q26864697 | Noncoding RNAs in DNA repair and genome integrity |
| Q27011225 | Noncoding RNAs in cancer and cancer stem cells |
| Q90464453 | Noncoding RNAs in gastric cancer: implications for drug resistance |
| Q34982347 | Notch signaling proteins: legitimate targets for cancer therapy |
| Q37437391 | Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression. |
| Q24564267 | Novel therapeutic targets for pancreatic cancer |
| Q34382586 | Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies |
| Q50148274 | Overexpression of MicroRNA-34a-5p Inhibits Proliferation and Promotes Apoptosis of Human Cervical Cancer Cells by Downregulation of Bcl-2. |
| Q27011547 | P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy |
| Q34326627 | Pathogenetic mechanisms in gastric cancer |
| Q90836137 | Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours |
| Q26744362 | Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer |
| Q54235737 | Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL. |
| Q38263343 | Promoter methylated microRNAs: potential therapeutic targets in gastric cancer |
| Q41412828 | RASSF1A inhibits gastric cancer cell proliferation by miR-711- mediated downregulation of CDK4 expression |
| Q28645941 | Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 |
| Q38359738 | Regulation of breast cancer stem cell features |
| Q38068926 | Regulation of breast cancer tumorigenesis and metastasis by miRNAs |
| Q26853096 | Regulation of ovarian cancer stem cells or tumor-initiating cells |
| Q37513688 | Regulation of stem cell populations by microRNAs |
| Q39099572 | Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness |
| Q91716127 | Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis |
| Q42161527 | Role of Notch signaling pathway in gastric cancer pathogenesis |
| Q33749954 | Role of miR-34c microRNA in the late steps of spermatogenesis |
| Q38237787 | Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis. |
| Q28072650 | Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells |
| Q92840766 | Serum miR-34a is a potential diagnostic and prognostic marker for osteosarcoma |
| Q35070602 | Shielding the messenger (RNA): microRNA-based anticancer therapies |
| Q38040324 | Smoke-induced microRNA and related proteome alterations. Modulation by chemopreventive agents. |
| Q34205088 | Targeting Notch signaling pathway to overcome drug resistance for cancer therapy |
| Q26771701 | Targeting Notch to overcome radiation resistance |
| Q38309242 | Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer |
| Q38254181 | The cancer stem cell hypothesis: a guide to potential molecular targets |
| Q34220723 | The clinical potential of microRNAs |
| Q38009641 | The emerging functions of the p53-miRNA network in stem cell biology |
| Q38156047 | The emerging role of miR-375 in cancer |
| Q35599477 | The emerging role of microRNAs in drug responses |
| Q26742058 | The expanding regulatory universe of p53 in gastrointestinal cancer |
| Q52332705 | The function of Notch1 intracellular domain in the differentiation of gastric cancer. |
| Q28245865 | The miR-34 family in cancer and apoptosis |
| Q36245752 | The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene |
| Q64105194 | The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors |
| Q26744831 | The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression |
| Q37765383 | The next thing in prognostic molecular markers: microRNA signatures of cancer |
| Q37625833 | The p53 Pathway Encounters the MicroRNA World |
| Q33787947 | The p53 Transcriptional Network Influences Microglia Behavior and Neuroinflammation |
| Q38210767 | The p53/miR-34 axis in development and disease |
| Q38261312 | The p53/microRNA connection in gastrointestinal cancer |
| Q36111707 | The predictive effect of overexpressed miR-34a on good survival of cancer patients: a systematic review and meta-analysis |
| Q35480938 | The prognostic value of miR-34a expression in completely resected gastric cancer: tumor recurrence and overall survival |
| Q36228497 | The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis |
| Q39152624 | The role of exosomes and miRNAs in drug-resistance of cancer cells. |
| Q47117573 | The role of miRNA and lncRNA in gastric cancer |
| Q37934681 | The role of miRNA in the direct and indirect effects of ionizing radiation |
| Q36158807 | The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis |
| Q37601781 | The role of microRNAs in endometriosis and associated reproductive conditions |
| Q38694209 | The roles of microRNA-34b-5p in angiogenesis of thyroid carcinoma. |
| Q36887716 | Therapeutic strategies targeting cancer stem cells |
| Q36833275 | Therapeutic targeting of the p53 pathway in cancer stem cells. |
| Q35876143 | Therapy-, gender- and race-specific microRNA markers, target genes and networks related to glioblastoma recurrence and survival. |
| Q37822465 | Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers |
| Q33764768 | Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways |
| Q37291308 | Twist and miR-34a are involved in the generation of tumor-educated myeloid-derived suppressor cells |
| Q28236711 | Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation |
| Q28393225 | Yin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesis |
| Q34640230 | miR-34 - a microRNA replacement therapy is headed to the clinic |
| Q38784668 | miR-34 activity is modulated through 5'-end phosphorylation in response to DNA damage |
| Q26822928 | miR-34: from bench to bedside |
| Q34722558 | miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma |
| Q38807275 | miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expression |
| Q53007110 | miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. |
| Q39061607 | miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells |
| Q35113386 | miRNA - Therapeutic tool in breast cancer? Where are we now? |
| Q35889599 | miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells. |
| Q54239648 | miRNA27a is a biomarker for predicting chemosensitivity and prognosis in metastatic or recurrent gastric cancer. |
| Q37211784 | miRNA: The nemesis of gastric cancer (Review). |
| Q39407845 | miRNA: the new frontier in cancer medicine |
| Q26747138 | miRNAs Signature in Head and Neck Squamous Cell Carcinoma Metastasis: A Literature Review |
| Q38633144 | miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance |
| Q39388462 | miRNAs expressed differently in cancer stem cells and cancer cells of human gastric cancer cell line MKN-45. |
| Q39143971 | microRNA regulation of human pancreatic cancer stem cells |
| Q36225874 | microRNA signature for human pancreatic cancer invasion and metastasis |
| Q38160950 | microRNAs in cancer cell response to ionizing radiation. |
Search more.